Drug
Ptc857
Ptc857: highest development phase Phase 2, developed by PTC Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- PTC Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| PTC857 NCT05349721 | Phase 2 | Amyotrophic Lateral Sclerosis |
Latest
No recent events.
Follow Ptc857 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.